Chemoinformaics analysis of 2,3-Dihydroamentoflavone
| Molecular Weight | 540.48 | nRot | 3 |
| Heavy Atom Molecular Weight | 520.32 | nRig | 36 |
| Exact Molecular Weight | 540.106 | nRing | 6 |
| Solubility: LogS | -5.436 | nHRing | 2 |
| Solubility: LogP | 5.575 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 5 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 4 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 28 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 29 |
| nHA | 10 | APOL | 71.4559 |
| nHD | 6 | BPOL | 25.2721 |
| QED | 0.181 |
| Synth | 3.542 |
| Natural Product Likeliness | 1.602 |
| NR-PPAR-gamma | 0.967 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.026 |
| Pgp-sub | 0.001 |
| HIA | 0.513 |
| CACO-2 | -5.418 |
| MDCK | 0.00000602 |
| BBB | 0.001 |
| PPB | 0.981446 |
| VDSS | 0.355 |
| FU | 0.0258954 |
| CYP1A2-inh | 0.753 |
| CYP1A2-sub | 0.105 |
| CYP2c19-inh | 0.783 |
| CYP2c19-sub | 0.037 |
| CYP2c9-inh | 0.771 |
| CYP2c9-sub | 0.907 |
| CYP2d6-inh | 0.084 |
| CYP2d6-sub | 0.264 |
| CYP3a4-inh | 0.281 |
| CYP3a4-sub | 0.081 |
| CL | 6.645 |
| T12 | 0.452 |
| hERG | 0.052 |
| Ames | 0.653 |
| ROA | 0.769 |
| SkinSen | 0.912 |
| Carcinogencity | 0.125 |
| EI | 0.897 |
| Respiratory | 0.046 |
| NR-Aromatase | 0.886 |
| Antiviral | Yes |
| Prediction | 0.70286 |